Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
18F-Fluciclovine Positron Emission Tomography in Men With Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Planning to Undergo Salvage Radiation Therapy: Results from LOCATE.
Solanki AA, Savir-Baruch B, Liauw SL, Michalski J, Tward JD, Vapiwala N, Teoh EJ; LOCATE study group. Solanki AA, et al. Pract Radiat Oncol. 2020 Sep-Oct;10(5):354-362. doi: 10.1016/j.prro.2020.05.007. Epub 2020 May 25. Pract Radiat Oncol. 2020. PMID: 32464368
VPAC1 Targeted 64Cu-TP3805 kit preparation and its evaluation.
Tripathi SK, Kumar P, Trabulsi EJ, Kim S, McCue PA, Intenzo C, Berger A, Gomella L, Thakur ML. Tripathi SK, et al. Among authors: intenzo c. Nucl Med Biol. 2017 Aug;51:55-61. doi: 10.1016/j.nucmedbio.2017.04.007. Epub 2017 May 3. Nucl Med Biol. 2017. PMID: 28577428 Free PMC article.
Imaging urothelial bladder cancer: A VPAC PET targeted approach.
Thakur ML, Tripathi SK, Gomella LG, Salmanoglu E, Kim S, Kelly WK, Keith SW, Intenzo C, McCue P, Hoffman-Censits J, Trabulsi EJ. Thakur ML, et al. Among authors: intenzo c. Can J Urol. 2021 Apr;28(2):10596-10602. Can J Urol. 2021. PMID: 33872557 Free article.
N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease.
Monti DA, Zabrecky G, Kremens D, Liang TW, Wintering NA, Bazzan AJ, Zhong L, Bowens BK, Chervoneva I, Intenzo C, Newberg AB. Monti DA, et al. Among authors: intenzo c. Clin Pharmacol Ther. 2019 Oct;106(4):884-890. doi: 10.1002/cpt.1548. Epub 2019 Jul 17. Clin Pharmacol Ther. 2019. PMID: 31206613 Clinical Trial.
(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies.
Picozzi VJ, Ramanathan RK, Lowery MA, Ocean AJ, Mitchel EP, O'Neil BH, Guarino MJ, Conkling PR, Cohen SJ, Bahary N, Frank RC, Dragovich T, Bridges BB, Braiteh FS, Starodub AN, Lee FC, Gribbin TE, Richards DA, Lee M, Korn RL, Pandit-Taskar N, Goldsmith SJ, Intenzo CM, Sheikh A, Manzone TC, Horne H, Sharkey RM, Wegener WA, O'Reilly EM, Goldenberg DM, Von Hoff DD. Picozzi VJ, et al. Among authors: intenzo cm. Eur J Cancer. 2015 Sep;51(14):1857-64. doi: 10.1016/j.ejca.2015.06.119. Epub 2015 Jul 14. Eur J Cancer. 2015. PMID: 26187510 Free article. Clinical Trial.
VPAC1 receptors for imaging breast cancer: a feasibility study.
Thakur ML, Zhang K, Berger A, Cavanaugh B, Kim S, Channappa C, Frangos AJ, Wickstrom E, Intenzo CM. Thakur ML, et al. Among authors: intenzo cm. J Nucl Med. 2013 Jul;54(7):1019-25. doi: 10.2967/jnumed.112.114876. Epub 2013 May 7. J Nucl Med. 2013. PMID: 23651947 Free PMC article.
119 results